Hancock BW - Search Results

1

Treatment of metastatic gestational trophoblastic neoplasia.

El-Helw LM, Hancock BW. El-Helw LM, et al. Among authors: hancock bw. Lancet Oncol. 2007 Aug;8(8):715-24. doi: 10.1016/S1470-2045(07)70239-5. Lancet Oncol. 2007. PMID: 17679081 Review.

2

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

El-Helw LM, Hancock BW. El-Helw LM, et al. Among authors: hancock bw. Future Oncol. 2009 May;5(4):445-53. doi: 10.2217/fon.09.13. Future Oncol. 2009. PMID: 19450173 Review.

3

VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.

El Helw LM, Lorigan PC, Robinson MH, Coleman RE, Hancock BW. El Helw LM, et al. Among authors: hancock bw. Int J Oncol. 2000 Apr;16(4):777-82. doi: 10.3892/ijo.16.4.777. Int J Oncol. 2000. PMID: 10717248

4

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia.

El-Helw LM, Seckl MJ, Haynes R, Evans LS, Lorigan PC, Long J, Kanfer EJ, Newlands ES, Hancock BW. El-Helw LM, et al. Among authors: hancock bw. Br J Cancer. 2005 Sep 19;93(6):620-1. doi: 10.1038/sj.bjc.6602771. Br J Cancer. 2005. PMID: 16222307 Free PMC article.

5

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.

El-Helw LM, Coleman RE, Everard JE, Tidy JA, Horsman JM, Elkhenini HF, Hancock BW. El-Helw LM, et al. Among authors: hancock bw. Gynecol Oncol. 2009 Jun;113(3):306-11. doi: 10.1016/j.ygyno.2009.02.006. Epub 2009 Mar 9. Gynecol Oncol. 2009. PMID: 19269684

6

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

El-Helw LM, Hancock BW. El-Helw LM, et al. Among authors: hancock bw. Expert Opin Investig Drugs. 2007 Oct;16(10):1683-91. doi: 10.1517/13543784.16.10.1683. Expert Opin Investig Drugs. 2007. PMID: 17922631 Review.

7

Primary B-cell lymphoma of the skin: the Sheffield Lymphoma Group Experience (1984-2003).

El-Helw L, Goodwin S, Slater D, Hancock BW. El-Helw L, et al. Among authors: hancock bw. Int J Oncol. 2004 Nov;25(5):1453-8. doi: 10.3892/ijo.25.5.1453. Int J Oncol. 2004. PMID: 15492838

8

M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.

Singh K, Gillett S, Ireson J, Hills A, Tidy JA, Coleman RE, Hancock BW, Winter MC. Singh K, et al. Among authors: hancock bw. Int J Cancer. 2021 May 1;148(9):2335-2344. doi: 10.1002/ijc.33403. Epub 2020 Dec 4. Int J Cancer. 2021. PMID: 33210289 Free article.

9

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.

Winter MC, Tidy JA, Hills A, Ireson J, Gillett S, Singh K, Hancock BW, Coleman RE. Winter MC, et al. Among authors: hancock bw. Gynecol Oncol. 2016 Dec;143(3):565-570. doi: 10.1016/j.ygyno.2016.10.001. Epub 2016 Oct 15. Gynecol Oncol. 2016. PMID: 27756557

10

When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.

Balachandran K, Salawu A, Ghorani E, Kaur B, Sebire NJ, Short D, Harvey R, Hancock B, Tidy J, Singh K, Sarwar N, Winter MC, Seckl MJ. Balachandran K, et al. Gynecol Oncol. 2019 Oct;155(1):8-12. doi: 10.1016/j.ygyno.2019.07.024. Epub 2019 Jul 30. Gynecol Oncol. 2019. PMID: 31375268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page